Search Results 1291-1300 of 20455 for hepatitis

  1. A Multi-Center Study Evaluating KTE-X19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia - Mayo Clinic

    Known infection with HIV, hepatitis B (HBsAg positive) or hepatitis C virus (anti-HCV positive); Presence of fungal, bacterial, viral, or other infection ...

  2. Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma - Mayo Clinic

    ... hepatitis B (HepB), or hepatitis C (HepC) positive; Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic ...

  3. A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Patients - Mayo Clinic

    Chronic active or acute viral hepatitis A, B, or C infection, or hepatitis B or C carrier (testing required for hepatitis B and C). Unresolved non ...

  4. A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    Have active hepatitis B or hepatitis C defined as: o HBV: hepatitis B ... hepatitis B core antibody (HBc Ab) positive subjects; o HCV: HCV ribonucleic ...

  5. Gastroenterology and Hepatology - Doctors - Mayo Clinic

    sis, Autoimmune hepatitis, Alcoholic hepatitis, Hepatic encephalopathy. Show more areas of focus for Elizabeth J. Carey, M.D. ...

  6. Gastroenterology and Hepatology - Doctors - Mayo Clinic

    sis, Autoimmune hepatitis, Alcoholic hepatitis, Hepatic encephalopathy. Show more areas of focus for Elizabeth J. Carey, M.D. ...

  7. A Study of AP160-Complex in Advanced Solid Tumors - Mayo Clinic

    History of liver disease such as cirrhosis, chronic active hepatitis, chronic persistent hepatitis or hepatitis B or C;; Active infection requiring ...

  8. Efavirenz, lamivudine, and tenofovir (oral route) - Side effects & dosage - Mayo Clinic

    This medicine may cause a hepatitis B infection to worsen if you stop using it. Your doctor may check for the presence of hepatitis B before and during ...

  9. A Study to Evaluate the Effect of Olorinab on Gastrointestinal Transit in Patients with Irritable Bowel Syndrome - Mayo Clinic

    Negative hepatitis panel (including hepatitis B surface antigen [HBsAg] and hepatitis C virus antibody [anti-HCV]) and negative for human immunodeficiency ...

  10. Medical Research & Education - Mayo Clinic News Network

    'Our goal is to achieve a world without viral hepatitis'. Joel Streed. October 1, 2021. 9-30-2021 COVID-19 Media Only News Briefing: Treatments for COVID.